HDL-apoA-I exchange: rapid detection and association with atherosclerosis.

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.

High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolip...

Full description

Bibliographic Details
Main Authors:	Mark S Borja, Lei Zhao, Bradley Hammerson, Chongren Tang, Richard Yang, Nancy Carson, Gayani Fernando, Xiaoqin Liu, Madhu S Budamagunta, Jacques Genest, Gregory C Shearer, Franck Duclos, Michael N Oda
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24015188/?tool=EBI

Similar Items

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015-09-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.
by: P J Pussinen, et al.
Published: (1997-01-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown J.D., Ph.D., et al.
Published: (2008-01-01)

SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
by: Veneracion G. Cabana, et al.
Published: (1999-06-01)

In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
by: Catherine C. Hedrick, et al.
Published: (2001-04-01)

ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT[S]
by: Adelina Duka, et al.
Published: (2013-01-01)

Mechanisms of HDL deficiency in mice overexpressing human apoA-II
by: Josep Julve, et al.
Published: (2002-10-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL
by: Jeffrey W. Chisholm, et al.
Published: (2002-01-01)

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway
by: Maki Tsujita, et al.
Published: (2005-01-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates
by: Perry L. Colvin, et al.
Published: (1999-10-01)

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]
by: Fabiana Rached, et al.
Published: (2014-12-01)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
by: Wilson James M, et al.
Published: (2007-05-01)

ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice
by: Wei Weng, et al.
Published: (1999-06-01)

Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease.
by: Mark S Borja, et al.
Published: (2017-01-01)

An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
by: Shu-Chen Lu, et al.
Published: (2012-04-01)

Significance of the hydrophobic residues 225–230 of apoA-I for the biogenesis of HDL1[S]
by: Panagiotis Fotakis, et al.
Published: (2013-12-01)

Three-dimensional models of HDL apoA-I: implications for its assembly and function*
by: Michael J. Thomas, et al.
Published: (2008-09-01)

Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL
by: Laura Calabresi, et al.
Published: (2001-06-01)

ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes
by: A S Plump, et al.
Published: (1997-05-01)

Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
by: Hiroshi Hosoai, et al.
Published: (1999-04-01)

ApoE-containing HDL and the development of atherosclerosis
by: Zbigniew Zdrojewski, et al.
Published: (2015-06-01)

ApoE-containing HDL and the development of atherosclerosis
by: Agnieszka Ćwiklińska, et al.
Published: (2015-01-01)

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice
by: Matthijs Moerland, et al.
Published: (2007-12-01)

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1
by: Shen Qu, et al.
Published: (2007-07-01)

Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse
by: David K. Spady, et al.
Published: (1998-07-01)

Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
by: Jonathan Dalla-Riva, et al.
Published: (2013-05-01)

Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice
by: David Masson, et al.
Published: (2008-08-01)

APOA1-75 G to A Substitution Associated with Severe Forms of CAD, Lower Levels of HDL and apoA-I among Northern Indians
by: S. Chhabra, et al.
Published: (2005-01-01)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
by: Toshimi Kido, et al.
Published: (2017-11-01)

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
by: Fayanne E. Thorngate, et al.
Published: (2003-12-01)

An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration
by: Xun Chen, Charlotte Burton, Xuelei Song, Lesley Mcnamara, Annunziata Langella, Simona Cianetti, Ching H. Chang, Jun Wang
Published: (2009-01-01)

Role of the hydrophobic and charged residues in the 218–226 region of apoA-I in the biogenesis of HDL1[S]
by: Panagiotis Fotakis, et al.
Published: (2013-12-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
by: Bruno Vergès, et al.
Published: (2009-06-01)

Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function
by: Miriam Lee, et al.
Published: (2000-06-01)

Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL
by: Kei-ichiro Okuhira, et al.
Published: (2004-04-01)